Identifying statin-associated autoimmune necrotizing myopathy

被引:21
作者
Albayda, Jemima [1 ]
Christopher-Stine, Lisa [2 ,3 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Med & Instructor Med, Div Rheumatol, Baltimore, MD 21224 USA
[2] Johns Hopkins Univ, Johns Hopkins Myositis Ctr, Div Rheumatol, Baltimore, MD 21224 USA
[3] Johns Hopkins Univ, Sch Med, Baltimore, MD 21224 USA
关键词
ANTI-3-HYDROXY-3-METHYLGLUTARYL-COENZYME; THERAPY; SAFETY;
D O I
10.3949/ccjm.81a.13158
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Statins up-regulate expression of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR), the rate-limiting enzyme in cholesterol synthesis and the major target of autoantibodies in statin-associated immune-mediated necrotizing myopathy. As muscle cells regenerate, they express high levels of HMGCR, which may sustain the immune response even after statin therapy is stopped. Awareness of this entity will help physicians who prescribe statins to take action to limit the associated morbidity.
引用
收藏
页码:736 / 741
页数:6
相关论文
共 15 条
[1]   Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients -: The PRIMO study [J].
Bruckert, E ;
Hayem, G ;
Dejager, S ;
Yau, C ;
Bégaud, B .
CARDIOVASCULAR DRUGS AND THERAPY, 2005, 19 (06) :403-414
[2]   A Novel Autoantibody Recognizing 200-kd and 100-kd Proteins Is Associated With an Immune-Mediated Necrotizing Myopathy [J].
Christopher-Stine, Lisa ;
Casciola-Rosen, Livia A. ;
Hong, Grace ;
Chung, Tae ;
Corse, Andrea M. ;
Mammen, Andrew L. .
ARTHRITIS AND RHEUMATISM, 2010, 62 (09) :2757-2766
[3]   Statin Myopathy: A Lipid Clinic Experience on the Tolerability of Statin Rechallenge [J].
Fung, En C. ;
Crook, Martin A. .
CARDIOVASCULAR THERAPEUTICS, 2012, 30 (05) :e212-e218
[4]   REGULATION OF THE MEVALONATE PATHWAY [J].
GOLDSTEIN, JL ;
BROWN, MS .
NATURE, 1990, 343 (6257) :425-430
[5]   IMMUNE-MEDIATED NECROTIZING MYOPATHY ASSOCIATED WITH STATINS [J].
Grable-Esposito, Phyllis ;
Katzberg, Hans D. ;
Greenberg, Steven A. ;
Srinivasan, Jayashri ;
Katz, Jonathan ;
Amato, Anthony A. .
MUSCLE & NERVE, 2010, 41 (02) :185-190
[6]   Clinical and laboratory phenotype of patients experiencing statin intolerance attributable to myalgia [J].
Harris, Leonard J. ;
Thapa, Rashmi ;
Brown, Michael ;
Pabbathi, Sabitha ;
Childress, Richard D. ;
Heimberg, Murray ;
Braden, Ron ;
Elam, Marshall B. .
JOURNAL OF CLINICAL LIPIDOLOGY, 2011, 5 (04) :299-307
[7]   Statin-Associated Rhabdomyolysis: Is There a Dose-Response Relationship? [J].
Holbrook, Anne ;
Wright, Mitchell ;
Sung, Melani ;
Ribic, Christine ;
Baker, Steven .
CANADIAN JOURNAL OF CARDIOLOGY, 2011, 27 (02) :146-151
[8]   Statin safety: A systematic review [J].
Law, M ;
Rudnicka, AR .
AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (8A) :52C-60C
[9]  
Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936
[10]   Rarity of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies in statin users, including those with self-limited musculoskeletal side effects [J].
Mammen, Andrew L. ;
Pak, Katherine ;
Williams, Emma K. ;
Brisson, Diane ;
Coresh, Joe ;
Selvin, Elizabeth ;
Gaudet, Daniel .
ARTHRITIS CARE & RESEARCH, 2012, 64 (02) :269-272